Search Within

Ross Levine

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (119)
  2. Meeting Abstract (82)
  3. Research Letter (3)
  4. Conference Paper (2)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Adult Leukemia (208)
  2. Center for Hematologic Malignancies (208)
  3. Department of Medicine (208)
  4. Executive Committee, Center for Hematologic Malignancies (208)
  5. GSK Faculty (208)
  6. Hematologic Malignancies, Division of (208)

More Groups

People
  1. Omar Abdel-Wahab (43)
  2. Martin Tallman (42)
  3. Maria Kleppe (40)
  4. Robert Bowman (30)
  5. Raajit Rampal (28)
  6. Wenbin Xiao (28)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (13)
  4. 2022 (10)
  5. 2021 (12)
  6. 2020 (17)

More Years

Publications
  1. Blood (73)
  2. Nature (11)
  3. Cancer Cell (10)
  4. Cancer Research (10)
  5. Cancer Discovery (8)
  6. Haematologica (8)

More Publications

Publishers
  1. American Society of Hematology (78)
  2. Nature Publishing Group (37)
  3. American Association for Cancer Research (27)
  4. Cell Press (20)
  5. Ferrata Storti Foundation (8)
  6. Rockefeller University Press (5)

More Publishers

Results (208)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Puga, R. D.; Paiva, R. D. A.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Comprehensive single-cell RNA-sequencing mapping of primary acute myeloid leukemias and profiling of NPM1-mutated cells
    Meeting Abstract

    Lavallee, V. P.; Azizi, E.; Kiseliovas, V.; Masilionis, I.; Mazutis, L.; Levine, R. L.; Pe'er, D.
    Blood (2018)

    Fulltext@MSK | Save
  • Ruxolitinib in combination with dasatinib and dexamethasone is an active and well-tolerated chemotherapy-sparing oral induction regimen for adults with Philadelphia chromosome-positive ALL: Results of a phase I trial
    Meeting Abstract

    Geyer, M. B.; Burke, P. W.; King, A. C.; Mauro, M. J.; Tallman, M. S.; Levine, R. L.; Sherr, C. J.; Douer, D.; Park, J. H.
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Genomic and proteomic profiling of AF10-fusion oncoproteins reveal mechanisms of leukemogenesis and actionable targets
    Meeting Abstract

    Chen, B. R.; Deshpande, A.; Kleppe, M.; Yeddula, N.; Yoh, S.; Armstrong, S. A.; Levine, R. L.; Chanda, S.; Deshpande, A. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save